Synlogic (NASDAQ: SYBX)
$1.36
(-3.6%)
-$0.05
Price as of December 27, 2024, 3:54 p.m. ET
Synlogic Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Synlogic Company Info
Synlogic, Inc. engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on August 28, 2017, and is headquartered in Cambridge, MA.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.